Home
/
Alcides articles
Home
News
General News
General Crypto News
Facebook
Amazon
Apple
Netflix
Google
Insights
Market Performance
About us
About us
Terms and Conditions
Privacy Policy
Contact us
My Account
2 Stocks I Am Thankful For in my Portfolio
AMZN | -1.49%
META | -1.48%
2 Stocks to Avoid During the Bull Market
CART | -3.78%
PINS | -0.83%
Tesla Stock: Buy the Musk Discount?
TSLA | -1.36%
NVIDIA Earnings Preview: Holding up the Market
NVDA | -2.68%
2 Cheap Stocks to Buy for a 2024 Rebound
BABA | -1.30%
PYPL | 0.34%
2 Stocks for the New Crypto Bull Market
COIN | 5.48%
HOOD | 2.47%
2 Earnings Misses to Buy Now
UBER | 2.23%
TTD | -3.97%
About the Author
Alcides is a Cell Bio graduate, finishing a PhD in Neuroscience. Writes about life sciences, pharma, and biotech.
Neuralink presents LINK V0.9
Elon Musk delivers on his promise.
By Alcides |
3 years ago
TSLA
Provention Bio's novel diabetes treatment
Under looked biotech company might be near tipping point
By Alcides |
3 years ago
PRVB
Novo Nordisk in the expanding market of diabetes care
The Danish multinational offers an exciting growth opportunity.
By Alcides |
3 years ago
NVO
The COVID-19 vaccine market will not be a winner-takes-all
The US government has selected three vaccine candidates to fund their Phase 3 trials through Operation Warp Speed.
By Alcides |
3 years ago
AZN
BNTX
MRNA
PFE
Load More